SCHEMBL812709

SCHEMBL812709

CSC(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.56
MEN1 O00255 2/20 0.56
CES1 P23141 6/20 0.50
CES2 O00748 5/20 0.50
TSHR P16473 3/20 0.50
ALDH1A1 P00352 3/20 0.50
DAO P14920 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
MAPT P10636 3/20 0.47
MAPK1 P28482 3/20 0.47
LMNA P02545 2/20 0.47
XBP1 P17861 1/20 0.47
RAB9A P51151 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TDP1 Q9NUW8 3/20 0.46
CYP3A4 P08684 2/20 0.46
CA2 P00918 2/20 0.46
CA4 P22748 2/20 0.46
POLB P06746 1/20 0.46
PARP1 P09874 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6682457 0.97 KMT2A (0.54) KMT2AMEN1CES1CES2TSHR
SCHEMBL9170977 0.86 SMN1; SMN2 (0.59) ALDH1A1MAPTLMNARAB9AL3MBTL1
SCHEMBL14270158 0.83 HPGD (0.66) KMT2AMEN1ALDH1A1MAPTMAPK1
SCHEMBL5031044 0.80 KMT2A (0.47) KMT2AMEN1CES1CES2TSHR
SCHEMBL4453783 0.78 CES1 (0.55) KMT2AMEN1CES1CES2TSHR
SCHEMBL168007 0.78 CES1 (0.55) KMT2AMEN1CES1CES2TSHR
SCHEMBL28152223 0.77 TSHR (0.55) KMT2AMEN1CES1CES2TSHR
SCHEMBL775142 0.77 ALDH1A1 (0.56) KMT2AMEN1CES1CES2ALDH1A1
SCHEMBL11771370 0.77 HPGD (0.52) CES2MAPTMAPK1LMNARAB9A
SCHEMBL24812337 0.77 AKR1C3 (0.66) ALDH1A1LMNARAB9APOLBAKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 466 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974758-B Carboxymethyl ketone compound and preparation method thereof 生物岛实验室 2025-06-10 CN claimed
US-20240306688-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2024-09-19 US claimed
CN-118515594-A Preparation of thiobenzene method for preparing methyl formate 常州大学 2024-08-20 CN claimed
EP-4391827-A1 METHOD OF MITIGATING OFF-ODORS Givaudan SA (CH) 2024-07-03 EP claimed
CN-117897055-A Method for reducing abnormal odor 奇华顿股份有限公司 2024-04-16 CN claimed
US-11844854-B2 Fragrance materials THE PROCTER & GAMBLE COMPANY (US) 2023-12-19 US claimed
CN-116913578-A Main grid silver paste for HJT battery and preparation method thereof 江苏正能电子科技有限公司 2023-10-20 CN claimed
CN-114716870-B LED curing shading ink for display screen and preparation method thereof 滁州金桥德克新材料有限公司无锡分公司 2023-08-08 CN claimed
WO-2023025549-A1 METHOD OF MITIGATING OFF-ODORS GIVAUDAN SA (CH) 2023-03-02 WO claimed
CN-110467739-B CPI (common reference character) hardening film for flexible folding screen 新恒东薄膜材料(常州)有限公司 2022-06-21 CN claimed
US-20040242933-A1 Process for preparation of ethene derivatives NIPPON SODA CO., LTD. (JP) 2004-12-02 US claimed
EP-1439171-A1 PROCESS FOR PREPARATION OF ETHENE DERIVATIVES NIPPON SODA CO., LTD. (JP) 2004-07-21 EP claimed
CN-1376672-A O-substituted benzene (alkyl) sulfenyl benzoic acid as plant growth regulator UNIV NANKAI (CN) 2002-10-30 CN claimed
US-5705527-A VASODILATORS AND ANGINA PECTORIS SANKYO COMPANY, LIMITED (JP) 1998-01-06 US claimed
EP-0641769-B1 AMINO ACID DERIVATIVE SANKYO CO (JP) 1997-01-29 EP claimed
EP-0641769-A1 AMINO ACID DERIVATIVE SANKYO COMPANY LIMITED (JP) 1995-03-08 EP claimed
EP-0127541-B1 SALTS OF AMINO-BETA-LACTAMIC ACIDS AND PROCESS FOR THE PREPARATION THEREOF GEMA S.A. (ES) 1990-08-01 EP claimed
US-4265892-A Cephalosporins having an α-acylaminoacetic acid side chain CIBA-GEIGY CORPORATION (US) 1981-05-05 US claimed
US-4041161-A ANTIBIOTICS CIBA-GEIGY CORPORATION (US) 1977-08-09 US claimed
US-4015000-A 6-Acylamino-penam-3-carboxylic and 7-acylamino-3-cephem-4-carboxylic acids CIBA-GEIGY CORPORATION (US) 1977-03-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040242933-A1 Process for preparation of ethene derivatives EPB41, NR2E1, ESR2 KMT2A 4089/4885MEN1 2880/4885CES1 1289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.